Description
Developer of a genome editing technology. The company offers genomic engineering products and services such as clustered regularly inter-spaced short palindromic repeats, CRISPR and Cas-related systems.
Contact Information
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
2. Out of Business | 01-Nov-2016 | Completed | Out of Business | |||
1. Accelerator/Incubator | 28-Oct-2015 | Completed | Startup |
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
US-20180080051-A1 | Cas 9 retroviral integrase and cas 9 recombinase systems for targeted incorporation of a dna sequence into a genome of a cell or organism | Inactive | 31-Mar-2015 | 0000000000 | |
EP-3277805-A1 | Cas 9 retroviral integrase and cas 9 recombinase systems for targeted incorporation of a dna sequence into a genome of a cell or organism | Pending | 31-Mar-2015 | 000000000 | |
JP-2018513681-A | Cas9 retroviral integrase and cas9 recombinase system for targeted integration of dna sequences into the genome of a cell or organism | Pending | 31-Mar-2015 | 000000000 | |
JP-2021176301-A | Cas 9 retroviral integrase and cas 9 recombinase systems for targeted incorporation of dna sequence into genome of cell or organism | Pending | 31-Mar-2015 | 000000000 | 0 |
US-20220315952-A1 | Cas 9 retroviral integrase and cas 9 recombinase systems for targeted incorporation of a dna sequence into a genome of a cell or organism | Pending | 31-Mar-2015 | C12N15/85 |